{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:58:37Z","timestamp":1762505917649},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T00:00:00Z","timestamp":1336003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2210-12-3","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T14:19:08Z","timestamp":1336054748000},"source":"Crossref","is-referenced-by-count":30,"title":["Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors"],"prefix":"10.1186","volume":"12","author":[{"given":"John","family":"Cuppoletti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony T","family":"Blikslager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayati","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant K","family":"Nighot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danuta H","family":"Malinowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,3]]},"reference":[{"key":"967_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1053\/j.gastro.2007.06.067","volume":"133","author":"V Andresen","year":"2007","unstructured":"Andresen V, Camilleri M, Busciglio IA, Grudell A, Burton D, McKinzie S, Foxx-Orenstein A, Kurtz CB, Sharma V, Johnston JM, Currie MG, Zinsmeister AR: Effect of 5\u2009days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology. 2007, 133: 761-768. 10.1053\/j.gastro.2007.06.067.","journal-title":"Gastroenterology"},{"key":"967_CR2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1358\/dof.2008.033.07.1214164","volume":"33","author":"V Andresen","year":"2008","unstructured":"Andresen V, Camilleri M: Linaclotide acetate. Guanylate cyclaseC receptor agonist treatment of irritable bowel syndrome and treatment of constipation. Drugs of the Future. 2008, 33: 570-576. 10.1358\/dof.2008.033.07.1214164.","journal-title":"Drugs of the Future"},{"key":"967_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/ajg.2008.59","volume":"104","author":"JM Johnston","year":"2009","unstructured":"Johnston JM, Kurtz CB, Drossman DA, Lembo AJ, Jeglinsli BI, MacDougall JE, Antonelli SM, Currie MG: Pilot study on the effect of linaclotide in patients with chronic constipation. Am J Gastroenterol. 2009, 104: 125-132. 10.1038\/ajg.2008.59.","journal-title":"Am J Gastroenterol"},{"key":"967_CR4","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1053\/j.gastro.2009.12.050","volume":"138","author":"AJ Lembo","year":"2010","unstructured":"Lembo AJ, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, Jeglinski BI, Johnston JM: Efficacy of linaclotide for patients with chronic constipation. Gastroenterology. 2010, 138: 886-895. 10.1053\/j.gastro.2009.12.050.","journal-title":"Gastroenterology"},{"key":"967_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1053\/j.gastro.2010.01.022","volume":"138","author":"AE Bharucha","year":"2010","unstructured":"Bharucha AE, Waldmon SA: Taking a lesson from microbial diarrheagenesis in the management of chronic constipation. Gastroenterology. 2010, 138: 813-817. 10.1053\/j.gastro.2010.01.022.","journal-title":"Gastroenterology"},{"key":"967_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1586\/egh.11.30","volume":"5","author":"MV Rogue","year":"2011","unstructured":"Rogue MV, Camilleri M: Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation. Expert Rev Gastroenterol Hepatol. 2011, 5: 301-310. 10.1586\/egh.11.30.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"967_CR7","doi-asserted-by":"publisher","first-page":"17758","DOI":"10.1074\/jbc.M110627200","volume":"277","author":"A Sindi\u0107e","year":"2002","unstructured":"Sindi\u0107e A, Ba\u015foglu C, Cer\u00e7i A, Hirsch JR, Potthast R, Kuhn M, Ghanekar Y, Visweswariah SS, Schlatter E: Guanylin, uroguanylin, and heat-stable enterotoxin activate guanylate cyclase C and\/or a pertussis toxin-sensitive G protein in human proximal tubule cells. J Biol Chem. 2002, 277: 17758-17764. 10.1074\/jbc.M110627200.","journal-title":"J Biol Chem"},{"key":"967_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ejphar.2010.09.019","volume":"649","author":"RW Busby","year":"2010","unstructured":"Busby RW, Bryant AP, Bartolini WP, Cordero EA, Hannig G, Kessler MM, Mahajan-Miklos S, Pierce CM, Solinga RM, Sun LJ, Tobin JV, Kurtz CB, Currie MG: Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit. Euro J Pharmacol. 2010, 649: 328-335. 10.1016\/j.ejphar.2010.09.019.","journal-title":"Euro J Pharmacol"},{"key":"967_CR9","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.lfs.2010.03.015","volume":"86","author":"AP Bryant","year":"2010","unstructured":"Bryant AP, Busby RW, Bartolini WP, Cordero EA, Hannig G, Kessler MM, Pierce CM, Solinga RM, Tobin JV, Mahajan-Miklos S, Cohen MB, Kurtz CB, Currie MG: Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract. Life Sci. 2010, 86: 760-765. 10.1016\/j.lfs.2010.03.015.","journal-title":"Life Sci"},{"key":"967_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1365-2982.2009.01385.x","volume":"22","author":"H Eutamene","year":"2010","unstructured":"Eutamene H, Bradesi S, Larauche M, Theodorou V, Beaufrand C, Ohning G, Fioramonti J, Cohen M, Bryant AP, Kurtz C, Currie MG, Mayer EA, Bueno L: Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain. Neurogastroenterol Motil. 2010, 22: 312-384. 10.1111\/j.1365-2982.2009.01385.x.","journal-title":"Neurogastroenterol Motil"},{"key":"967_CR11","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1053\/j.gastro.2010.08.041","volume":"139","author":"JM Johnston","year":"2010","unstructured":"Johnston JM, Kurtz CB, MacDougall JE, Lavins BJ, Currie MG, Fitch DA, O\u2019Dea C, Baird M, Lembo AJ: Linaclotide improves abdominal pain and bowel habits in a Phase IIb study of patients with irritable bowel syndrome with constipation. Gastroenterology. 2010, 139: 1877-1886. 10.1053\/j.gastro.2010.08.041.","journal-title":"Gastroenterology"},{"key":"967_CR12","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s10620-009-1068-x","volume":"55","author":"CF Barish","year":"2010","unstructured":"Barish CF, Drossman D, Johanson JF, Ueno R: Efficacy and safety of lubiprostone in patients with chronic constipation. Dig Dis Sci. 2010, 55: 1090-1097. 10.1007\/s10620-009-1068-x.","journal-title":"Dig Dis Sci"},{"key":"967_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2036.2008.03881.x","volume":"29","author":"DA Drossman","year":"2009","unstructured":"Drossman DA, Chey WD, Johanson JF, Fass R, Scott C, Panas R, Ueno R: Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome\u2013results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther. 2009, 29: 329-341. 10.1111\/j.1365-2036.2008.03881.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"967_CR14","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s10620-011-1702-2","volume":"56","author":"R Schey","year":"2011","unstructured":"Schey R, Rao SS: Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome. Dig Dis Sci. 2011, 56: 1619-1625. 10.1007\/s10620-011-1702-2.","journal-title":"Dig Dis Sci"},{"key":"967_CR15","first-page":"361","volume":"2","author":"TN Lunsford","year":"2010","unstructured":"Lunsford TN, Harris LA: Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome. Int J Women\u2019s Health. 2010, 2: 361-374.","journal-title":"Int J Women\u2019s Health"},{"key":"967_CR16","doi-asserted-by":"publisher","first-page":"544-e205","DOI":"10.1111\/j.1365-2982.2011.01668.x","volume":"23","author":"S Fukudo","year":"2011","unstructured":"Fukudo S, Hongo M, Kaneko H, Ueno R: Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study. Neurogastroenterol Motil. 2011, 23: 544-e205-","journal-title":"Neurogastroenterol Motil"},{"key":"967_CR17","doi-asserted-by":"publisher","first-page":"C1173","DOI":"10.1152\/ajpcell.00528.2003","volume":"287","author":"J Cuppoletti","year":"2004","unstructured":"Cuppoletti J, Malinowska DH, Tewari KP, Li QJ, Sherry AM, Patchen ML, Ueno R: SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. Am J Physiol Cell Physiol. 2004, 287: C1173-C1183. 10.1152\/ajpcell.00528.2003.","journal-title":"Am J Physiol Cell Physiol"},{"key":"967_CR18","doi-asserted-by":"publisher","first-page":"G234","DOI":"10.1152\/ajpgi.00366.2007","volume":"295","author":"HF Bao","year":"2008","unstructured":"Bao HF, Liu L, Self J, Duke BJ, Ueno R, Eaton DC: A synthetic prostone activates apical chloride channels in A6 epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2008, 295: G234-G251. 10.1152\/ajpgi.00366.2007.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"967_CR19","first-page":"298","volume":"126","author":"R Ueno","year":"2004","unstructured":"Ueno R, Osama H, Habe T: Oral SPI-0211increases intestinal fluid secretion and chloride concentration without altering serum electrolyte levels. Gastroenterology. 2004, 126: 298-","journal-title":"Gastroenterology"},{"key":"967_CR20","doi-asserted-by":"publisher","first-page":"G942","DOI":"10.1152\/ajpgi.00264.2005","volume":"290","author":"M Camilleri","year":"2006","unstructured":"Camilleri M, Bharucha AE, Ueno R, Burton D, Thomforde GM, Baxter K, McKinzie S, Zinsmeister AR: Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2006, 290: G942-G947.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"967_CR21","doi-asserted-by":"publisher","first-page":"944-e400","DOI":"10.1111\/j.1365-2982.2011.01776.x","volume":"23","author":"WE Whitehead","year":"2011","unstructured":"Whitehead WE, Palsson OS, Gangarosa L, Turner M, Tucker J: Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2011, 23: 944-e400-","journal-title":"Neurogastroenterol Motil"},{"key":"967_CR22","doi-asserted-by":"publisher","first-page":"G647","DOI":"10.1152\/ajpgi.00183.2006","volume":"292","author":"AJ Moeser","year":"2007","unstructured":"Moeser AJ, Nighot PK, Engelke KJ, Ueno R, Blikslager AT: Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone. Am J Physiol Gastrointest Liver Physiol. 2007, 292: G647-G656.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"967_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.yexcr.2008.10.001","volume":"315","author":"PK Nighot","year":"2009","unstructured":"Nighot PK, Moeser AJ, Ryan KA, Ghashghaei T, Melvin JE, Blikslager AT: ClC-2 is required for rapid restoration of epithelial tight junctions in ischemic injured ileum. Exp Cell Res. 2009, 315: 110-118. 10.1016\/j.yexcr.2008.10.001.","journal-title":"Exp Cell Res"},{"key":"967_CR24","doi-asserted-by":"publisher","first-page":"6012","DOI":"10.3748\/wjg.14.6012","volume":"14","author":"AJ Moeser","year":"2008","unstructured":"Moeser AJ, Nighot PK, Roerig B, Ueno R, Blikslager AT: Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine. World J Gastroenterol. 2008, 14: 6012-6017. 10.3748\/wjg.14.6012.","journal-title":"World J Gastroenterol"},{"key":"967_CR25","doi-asserted-by":"publisher","first-page":"C178","DOI":"10.1152\/ajpcell.00072.2011","volume":"302","author":"PK Nighot","year":"2012","unstructured":"Nighot PK, Blikslager AT: Chloride channel ClC-2 modulates tight junction barrier function via intracellular trafficking of occludin. Am J Physiol Cell Physiol. 2012, 302: C178-C187. 10.1152\/ajpcell.00072.2011.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5 supp. 1","key":"967_CR26","first-page":"S-146","volume":"138","author":"J Cuppoletti","year":"2010","unstructured":"Cuppoletti J, Malinowska DH, Tewari KP, Chakrabarti J, Ueno R: Methadone, but not morphine inhibits stimulated chloride currents in ClC-2 transfected cells in culture. Gastroenterology. 2010, 138 (5 supp. 1): S-146-","journal-title":"Gastroenterology"},{"key":"967_CR27","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1365-2036.2004.02284.x","volume":"20","author":"JK Marshall","year":"2004","unstructured":"Marshall JK, Thabane M, Garg AX, Clark W, Meddings J, Collins SM, WEL Investigators: Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther. 2004, 20: 1317-1322. 10.1111\/j.1365-2036.2004.02284.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"967_CR28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2982.2007.00925.x","volume":"19","author":"M Camilleri","year":"2007","unstructured":"Camilleri M, Gorman H: Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil. 2007, 19: 545-552. 10.1111\/j.1365-2982.2007.00925.x.","journal-title":"Neurogastroenterol Motil"},{"key":"967_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/gut.2007.140806","volume":"58","author":"T Piche","year":"2009","unstructured":"Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M: Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut. 2009, 58: 196-201. 10.1136\/gut.2007.140806.","journal-title":"Gut"},{"key":"967_CR30","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s10620-009-0765-9","volume":"55","author":"APM Kerckhoffs","year":"2010","unstructured":"Kerckhoffs APM, Akkermans LMA, de Smet MBM, Besselink MGH, Hietbrink F, Bartelink IH, Busschers WB, Samson M, Renooij W: Intestinal permeability in irritable bowel syndrome patients: effect of NSAIDS. Dig Dis Sci. 2010, 55: 716-723. 10.1007\/s10620-009-0765-9.","journal-title":"Dig Dis Sci"},{"key":"967_CR31","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/ajg.2011.257","volume":"106","author":"N Bertiaux-Vandaele","year":"2011","unstructured":"Bertiaux-Vandaele N, Beutheu Youmba S, Belmonte L, Lecleire S, Antonietti JF, Gourcerol G, Leroi AM, Dechelotte P, Menard JF, Ducrotte P, Coeffier M: The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Am J Gastroenterol. 2011, 106: 2165-2173. 10.1038\/ajg.2011.257.","journal-title":"Am J Gastroenterol"},{"key":"967_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ajg.2011.315","volume":"107","author":"M Vivinus-Nebot","year":"2012","unstructured":"Vivinus-Nebot M, Dainese R, Anty R, Saint-Paul MC, Nano JL, Gonthier N, Marjoux S, Frin-Mathy G, Bernard G, Hebuteme X, Tran A, Theodorou V, Piche T: Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells. Am J Gastroenterol. 2012, 107: 75-81. 10.1038\/ajg.2011.315.","journal-title":"Am J Gastroenterol"},{"key":"967_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/jir.2008.0057","volume":"29","author":"C Beaurepaire","year":"2009","unstructured":"Beaurepaire C, Smyth D, McKay DM: Interferon-\u03b3 regulation of intestinal epithelial permeability. J Interferon Cytokine Res. 2009, 29: 133-143. 10.1089\/jir.2008.0057.","journal-title":"J Interferon Cytokine Res"},{"key":"967_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1749-6632.2009.04062.x","volume":"1165","author":"JD Schulzke","year":"2009","unstructured":"Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, Richter J, Bojarski C, Schumann M, Fromm M: Epithelial tight junctions in intestinal inflammation. Ann NY Acad Sci. 2009, 1165: 294-300. 10.1111\/j.1749-6632.2009.04062.x.","journal-title":"Ann NY Acad Sci"},{"key":"967_CR35","doi-asserted-by":"publisher","first-page":"27952","DOI":"10.1074\/jbc.M109.046292","volume":"284","author":"M Scharl","year":"2009","unstructured":"Scharl M, Paul G, Barrett KE, McCole DF: AMP-activated protein kinase mediates the interferon-\u03b3-induced decrease in intestinal epithelial barrier function. J Biol Chem. 2009, 284: 27952-27963. 10.1074\/jbc.M109.046292.","journal-title":"J Biol Chem"},{"key":"967_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1590\/S0100-879X2010007500020","volume":"43","author":"W Cui","year":"2010","unstructured":"Cui W, Li LX, Sun CM, Wen Y, Zhou Y, Dong YL, Liu P: Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells. Braz J Med Biol Res. 2010, 43: 330-337. 10.1590\/S0100-879X2010007500020.","journal-title":"Braz J Med Biol Res"},{"issue":"e22967","key":"967_CR37","first-page":"1","volume":"6","author":"K Juuti-Uusitalo","year":"2011","unstructured":"Juuti-Uusitalo K, Klunder LJ, Sjollema KA, Mackovicova K, Ohgaki R, Hoekstra D, Dekker J, van Ijzendoorn SCD: Differential effects of TNF (TNFSF2) and IFN-\u03b3 on intestinal epithelial cell morphogenesis and barrier function in three-dimensional culture. PLoS One. 2011, 6 (e22967): 1-12.","journal-title":"PLoS One"},{"key":"967_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/bip.21480","volume":"96","author":"M Gongora-Benitez","year":"2010","unstructured":"Gongora-Benitez M, Tulla-Puche J, Paradis-Bas M, Werbitzky O, Giraud M, Albericio F: Optimized Fmoc solid-phase synthesis of the cysteine-rich peptide linaclotide. Biopolymers (Pept Sci) PeptideScience. 2010, 96: 69-80.","journal-title":"Biopolymers (Pept Sci) PeptideScience"},{"key":"967_CR39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.bbamem.2006.12.015","volume":"1768","author":"J Cuppoletti","year":"2007","unstructured":"Cuppoletti J, Malinowska DH, Tewari KP, Chakrabarti J, Ueno R: Cellular and molecular effects of unoprostone as a BK channel activator. Biochim Biophys Acta. 2007, 1768: 1083-1092. 10.1016\/j.bbamem.2006.12.015.","journal-title":"Biochim Biophys Acta"},{"key":"967_CR40","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1073\/pnas.0434905100","volume":"100","author":"GM Pitari","year":"2003","unstructured":"Pitari GM, Zingman LV, Hodgson DM, Alekseev AE, Kazerounian S, Bienengraeber M, Hajn\u00f3czky G, Terzic A, Waldman SA: Bacterial enterotoxins are associated with resistance to colon cancer. Proc Natl Acad Sci USA. 2003, 100: 2695-2699. 10.1073\/pnas.0434905100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"967_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1046\/j.1462-5822.2000.00041.x","volume":"2","author":"S Uzzau","year":"2000","unstructured":"Uzzau S, Fasano A: Cross-talk between enteric pathogens and the intestine. Cell Microbiol. 2000, 2: 83-89. 10.1046\/j.1462-5822.2000.00041.x.","journal-title":"Cell Microbiol"}],"container-title":["BMC Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2210-12-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2210-12-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2210-12-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T06:21:48Z","timestamp":1548138108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1186\/1471-2210-12-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1186\/1471-2210-12-3","relation":{},"ISSN":["1471-2210"],"issn-type":[{"value":"1471-2210","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,3]]},"article-number":"3"}}